SEP 21, 2021 8:00 AM PDT

1 in 5 Hospitalized COVID Patients Develop Self-Destructive Antibodies

WRITTEN BY: Tara Fernandez

One in five hospitalized COVID-19 patients go on to develop autoantibodies—immune molecules that mistakenly target the body’s own tissues, says a new study. These antibodies, which can go on to cause autoimmune disease, were detected as early as a few days following hospitalization. The study was published in Nature Communications.

Scientists from Stanford Medicine analyzed blood samples from nearly 150 patients who were admitted for COVID-19 in search of autoantibodies. In particular, the team was interested in antibodies that specifically latched onto cytokines. 

The word “cytokine” originates from two Greek words: “cyto”, or cell, and “kinos”, meaning movement. These cell signaling molecules are part of the immune system’s sophisticated communication network, involved in coordinating responses to infections.

The researchers found that over 60 percent of all the COVID-19 patients studied had anti-cytokine antibodies, compared to just 15 percent of healthy controls. They hypothesize that because COVID-19 triggers a full-blown, often exaggerated inflammatory response, high circulating cytokine levels may spark the production of autoantibodies against them.

These anti-cytokine antibodies have the potential to make COVID symptoms much worse. If antibodies stop cytokines from functioning properly, virus-clearing immune mechanisms may become impaired, giving the virus the upper hand.

PJ Utz, study lead and professor of immunology at Stanford Medicine, says these findings further support why COVID-19 vaccinations are so critical. “It’s possible that, in the course of a poorly controlled SARS-CoV-2 infection—in which the virus hangs around for too long while an intensifying immune response continues to break viral particles into pieces—the immune system sees bits and pieces of the virus that it hadn’t previously seen,” Utz said. 

“If any of these viral pieces too closely resemble one of our own proteins, this could trigger autoantibody production.”

 

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 31, 2021
Clinical & Molecular DX
Five Questions to Help You Select the Best Cellular Stain
AUG 31, 2021
Five Questions to Help You Select the Best Cellular Stain
Cellular stains are organic fluorescent dyes or fluorescent conjugates designed to localize to a specific organelle or c ...
AUG 24, 2021
Immunology
Women Produce More COVID Antibodies Than Men
AUG 24, 2021
Women Produce More COVID Antibodies Than Men
An exploration into the human immune response after a COVID-19 infection has revealed a surprising finding: women produc ...
SEP 13, 2021
Microbiology
Flu Season Looms Large as World May Have an 'Immunity Debt'
SEP 13, 2021
Flu Season Looms Large as World May Have an 'Immunity Debt'
Scientists are beginning to speculate about the possibility that the flu season this year will be particularly bad becau ...
SEP 14, 2021
Drug Discovery & Development
A novel drug that targets the removal of pathogenic antibodies in myasthenia gravis
SEP 14, 2021
A novel drug that targets the removal of pathogenic antibodies in myasthenia gravis
Myasthenia gravis is a chronic autoimmune disorder characterized by muscle weakness and fatigue. The disorder leads to a ...
SEP 24, 2021
Drug Discovery & Development
WHO Recommends Antibody Treatment for High Risk COVID-19 Patients
SEP 24, 2021
WHO Recommends Antibody Treatment for High Risk COVID-19 Patients
The World Health Organization (WHO) has recommended a combination of two antibody treatments for patients at risk of adv ...
OCT 18, 2021
Cancer
The History of Immunotherapy: Toxins, Targets & T Cells
OCT 18, 2021
The History of Immunotherapy: Toxins, Targets & T Cells
Cancer immunotherapy, a treatment that directly enhances a patient’s immune system, is typically perceived as a mo ...
Loading Comments...